Medical Termination of First Trimester Miscarriages

Objective: To study the success rate of medical termination of first trimester non viable pregnancies with misoprostol 1200µg.The secondary end points were to study the prevalence of unwanted side effects. Study design : Interventional: Quasi experimental study. Setting: Department of Obstetrics & Gynaecology. Fatima Memorial Hospital Lahore. Study duration:   18 months (July 05 to January 07). Sample technique : Non-probable sampling: Purposive. Sample : Eighty one women seeking medical attention for early miscarriages. Method : Women with non viable, first trimester miscarriage were selected for termination with misoprostol 1200µg in divided doses over 24 hours. Main outcome measures: Main outcome measure was the proportion of successful resolution of miscarriage without surgical intervention. Secondary outcomes were incidence of pain, heavy vaginal bleeding (>500ml), infection, pyrexia and gastrointestinal side effects. Results: Eighty-one women were recruited in the study. Treatment was successful in 43 patients (53.1%) with 38 patients (46.9%) requiring surgical evacuation due to failure of treatment. Major side effect experienced by patient was pain (42.0%) requiring analgesia for relief. Nausea and vomiting was seen in (18.5%). Two patients (2.5%) had diarrhea and three patients (3.7%) had pyrexia. Five patients (6.2%) had heavy vaginal bleeding (>500ml). None had PID. Conclusion : Medical treatment of first trimester miscarriage is non-invasive and cost effective method of treatment and a safe alternative to D&C. Our study demonstrated the efficiency and safety of administration of 1200μg of misoprostol orally for management of missed, incomplete and an embryonic miscarriage. Keywords: Misoprostol, medical management, miscarriage.

[1]  A. Weeks,et al.  A Randomized Trial of Misoprostol Compared With Manual Vacuum Aspiration for Incomplete Abortion , 2005, Obstetrics and gynecology.

[2]  I. Milsom,et al.  A randomised double blind trial comparing misoprostol or placebo in the management of early miscarriage , 2005, BJOG : an international journal of obstetrics and gynaecology.

[3]  B. Mol,et al.  Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. , 2004, Human reproduction.

[4]  J. Moodley,et al.  A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. , 2004, Human reproduction.

[5]  P. Ho,et al.  A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages. , 2003, Human reproduction.

[6]  B. Winikoff,et al.  Misoprostol for Women's Health: A Review , 2002, Obstetrics and gynecology.

[7]  A. Templeton,et al.  Medical management of early fetal demise using a combination of mifepristone and misoprostol. , 2001, Human reproduction.

[8]  P. Ho,et al.  Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage. , 2001, Human reproduction.

[9]  E. Sarıdoğan,et al.  A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure , 2001, Human reproduction.

[10]  M. Hahlin,et al.  Randomised trial comparing expectant with medical management for first trimester miscarriages , 1999, British journal of obstetrics and gynaecology.

[11]  A. Chang,et al.  Spontaneous abortion: a randomized, controlled trial comparing surgical evacuation with conservative management using misoprostol. , 1999, Fertility and sterility.

[12]  S. Zalanyi.  Vaginal misoprostol alone is effective in the treatment of missed abortion , 1998, British journal of obstetrics and gynaecology.

[13]  D. Jurković.  Modern management of miscarriage: is there a place for non‐surgical treatment? , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[14]  A. Chang,et al.  Spontaneous Abortion: Short‐term Complications Following Either Conservative or Surgical Management , 1998, The Australian & New Zealand journal of obstetrics & gynaecology.

[15]  M. Hahlin,et al.  Unsuccessful treatment of missed abortion with a combination of an antiprogesterone and a prostaglandin E1 analogue , 1997, British journal of obstetrics and gynaecology.

[16]  Y. Herabutya,et al.  Misoprostol in the management of missed abortion , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[17]  K. Nicolaides,et al.  The prevalence of non‐viable pregnancy at 10–13 weeks of gestation , 1996, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[18]  R. Pattinson,et al.  Randomised clinical trial of medical evacuation and surgical curettage for incomplete miscarriage , 1995, BMJ.

[19]  M. Hahlin,et al.  Expectant management of first-trimester spontaneous abortion , 1995, The Lancet.

[20]  I. Rojas,et al.  [Expectant management of missed abortion]. , 1994, Revista chilena de obstetricia y ginecologia.

[21]  R. Henshaw,et al.  Medical management of miscarriage: non-surgical uterine evacuation of incomplete and inevitable spontaneous abortion. , 1993, BMJ.